DPP-4

DPP-4 inhibitors are compounds that inhibit Dipeptidyl Peptidase-4, an enzyme involved in the inactivation of incretin hormones, which regulate glucose metabolism. By inhibiting DPP-4, these compounds help prolong the action of incretin hormones, enhancing insulin secretion and reducing blood glucose levels. DPP-4 inhibitors are widely used in the treatment of type 2 diabetes and in research focused on metabolic disorders. At CymitQuimica, we offer DPP-4 inhibitors to support your research in endocrinology, diabetes management, and metabolic disease.